
Elevance Stock Slips After Wells Fargo Cuts Price Target Ahead Of Q2 Earnings: Retail’s Not Pessimistic Yet
Wells Fargo on Tuesday lowered its price target on health insurance provider Elevance Health (ELV) to $400 from $478 while keeping an ‘Overweight’ rating on the shares, The new price target still represents a near 18% upside to Elevance’s closing price on …